1051899-73-0 Usage
Description
(3-Amino-2-fluorophenyl)methanol is an organic compound characterized by the presence of an amino group at the 3rd position, a fluorine atom at the 2nd position, and a hydroxyl group attached to a benzene ring. This unique molecular structure endows it with specific chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(3-Amino-2-fluorophenyl)methanol is used as a reactant for the preparation of pyrazolylthiadiazolamine derivatives, which are compounds with potential therapeutic applications. Specifically, these derivatives are being investigated for their effectiveness in the treatment of tuberculosis, a bacterial infection that affects the lungs and can be life-threatening if not properly managed.
The application of (3-Amino-2-fluorophenyl)methanol in the pharmaceutical industry highlights its importance as a building block for the development of new drugs to combat tuberculosis, a disease that continues to pose a significant global health challenge. By contributing to the synthesis of pyrazolylthiadiazolamine derivatives, (3-Amino-2-fluorophenyl)methanol plays a crucial role in the ongoing efforts to discover and develop novel anti-tuberculosis agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1051899-73-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,1,8,9 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1051899-73:
(9*1)+(8*0)+(7*5)+(6*1)+(5*8)+(4*9)+(3*9)+(2*7)+(1*3)=170
170 % 10 = 0
So 1051899-73-0 is a valid CAS Registry Number.
1051899-73-0Relevant articles and documents
(PYRAZOL-3-YL)-1,3,4-THIADIAZOL-2-AMINE AND (PYRAZOL-3-YL)-1,3,4-THIAZOL-2-AMINE COMPOUNDS
-
Page/Page column 38, (2012/04/23)
A compound of Formula (I) wherein: either X is N and Y is CR5 or X is C and Y is S; Z is selected from N and CH; R1 is selected from H and Me; R2 is selected from H, OH, OMe and Me; each R3 is independently selected from C1-3alkyl, F, Cl, Br, CF3 and NH2; R4 is selected from Me, CF3, NO2 and CHF2; R5 is selected from H, Me and CHF2; R6 is selected from H and Me; and p is 0-3, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.
